4.855 USD
+0.23 (+4.86%)
Taking everything into account, BCTX scores 2 out of 10 in our fundamental rating. BCTX was compared to 525 industry peers in the Biotechnology industry. While BCTX seems to be doing ok healthwise, there are quite some concerns on its profitability. BCTX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- BCTX had negative earnings in the past year.
- BCTX had a negative operating cash flow in the past year.
- BCTX had negative earnings in each of the past 5 years.
- BCTX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- BCTX has a worse Return On Assets (-219.56%) than 89.14% of its industry peers.
- Looking at the Return On Equity, with a value of -287.71%, BCTX is doing worse than 72.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -219.56% | ||
| ROE | -287.71% | ||
| ROIC | N/A |
ROA(3y)-91.98%
ROA(5y)-72.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for BCTX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- BCTX has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BCTX has more shares outstanding
- BCTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -15.05, we must say that BCTX is in the distress zone and has some risk of bankruptcy.
- BCTX has a worse Altman-Z score (-15.05) than 79.62% of its industry peers.
- There is no outstanding debt for BCTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -15.05 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 3.42 indicates that BCTX has no problem at all paying its short term obligations.
- BCTX's Current ratio of 3.42 is in line compared to the rest of the industry. BCTX outperforms 41.14% of its industry peers.
- A Quick Ratio of 3.42 indicates that BCTX has no problem at all paying its short term obligations.
- BCTX has a Quick ratio (3.42) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.42 | ||
| Quick Ratio | 3.42 |
3. Growth
3.1 Past
- The earnings per share for BCTX have decreased strongly by -184.87% in the last year.
EPS 1Y (TTM)-184.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 18.83% on average over the next years. This is quite good.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y90.98%
EPS Next 2Y40.47%
EPS Next 3Y25.73%
EPS Next 5Y18.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for BCTX. In the last year negative earnings were reported.
- Also next year BCTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as BCTX's earnings are expected to grow with 25.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.47%
EPS Next 3Y25.73%
5. Dividend
5.1 Amount
- No dividends for BCTX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BRIACELL THERAPEUTICS CORP / BCTX FAQ
What is the ChartMill fundamental rating of BRIACELL THERAPEUTICS CORP (BCTX) stock?
ChartMill assigns a fundamental rating of 2 / 10 to BCTX.
Can you provide the valuation status for BRIACELL THERAPEUTICS CORP?
ChartMill assigns a valuation rating of 1 / 10 to BRIACELL THERAPEUTICS CORP (BCTX). This can be considered as Overvalued.
What is the profitability of BCTX stock?
BRIACELL THERAPEUTICS CORP (BCTX) has a profitability rating of 0 / 10.
How financially healthy is BRIACELL THERAPEUTICS CORP?
The financial health rating of BRIACELL THERAPEUTICS CORP (BCTX) is 6 / 10.